CoChat

Selective insulin resistance with differential expressions of IRS-1 and IRS-2 in human NAFLD livers

Open access

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Abstract

BACKGROUND/OBJECTIVE: Insulin signals, via the regulation of key enzyme expression, both suppress gluconeogenesis and enhance lipid synthesis in the liver. Animal studies have revealed insulin signaling favoring gluconeogenesis suppression to be selectively impaired in steatotic livers. However, whether, and if so how, such selective insulin resistance occurs in human steatotic livers remains unknown. Our aim was to investigate selective insulin resistance in human livers with non-alcoholic fatty liver disease (NAFLD). SUBJECTS/METHODS: We examined mRNA expressions of key molecules for insulin signaling, gluconeogenesis and lipogenesis in human liver biopsy samples obtained from 51 non-diabetic subjects: 9 healthy controls and 42 NAFLD patients, and analyzed associations of these molecules with each other and with detailed pathological and clinical biochemistry data. RESULTS: In NAFLD patients, insulin receptor substrate (IRS)-2 expression was decreased, while those of key enzymes for gluconeogenesis were increased. These alterations of IRS-2 and gluconeogenesis enzymes were induced both in simple steatosis (SS) and non-alcoholic steatohepatitis (NASH), while these expression levels did not differ between SS and NASH. Furthermore, alterations in the expressions of IRS-2 and gluconeogenesis enzymes showed strong negative correlations and were concurrently induced in the early histological stage of NAFLD. In contrast, fatty acid synthase (FAS) expression was not decreased in NAFLD, despite IRS-2 downregulation, but correlated strongly with IRS-1 expression. Furthermore, no histological scores were associated with these molecules. Thus, IRS-1 signaling, which is not impaired in NAFLD, appears to modulate FAS expression. CONCLUSION: These analyses revealed that selective insulin resistance is present in human NAFLD livers and occurs in its early phases. The effect of insulin, during the IRS step, on gene expressions for lipogenesis and gluconeogenesis are apparently distinct and preferential downregulation of IRS-2 may contribute to selective resistance to the suppressive effects of insulin on gluconeogenesis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41366-018-0062-9

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Gene expression levels in the livers of the three groups. The hepatic gene expression levels were compared among the control, SS, and NASH groups. Individual genes are normalized to CDKN1B mRNA levels. IRS-1 (a), IRS-2 (b), PEPCK (c), G6Pase (d), GCK (e), FAS (f), IR (g), and IR-B/IR-A ratio (h). The data from 51 human liver biopsies are shown. The top and bottom of each box indicate the 1st and 3rd quartiles (interquartile range, IGR), and the band inside the box is the median. The ends of the whiskers represent the minima and maxima without outliers. The value of P was determined by ANOVA with Tukey–Kramer post hoc testing. (*P < 0.05, **P < 0.01)
Fig. 1 Gene expression levels in the livers of the three groups. The hepatic gene expression levels were compared among the control, SS, and NASH groups. Individual genes are normalized to CDKN1B mRNA levels. IRS-1 (a), IRS-2 (b), PEPCK (c), G6Pase (d), GCK (e), FAS (f), IR (g), and IR-B/IR-A ratio (h). The data from 51 human liver biopsies are shown. The top and bottom of each box indicate the 1st and 3rd quartiles (interquartile range, IGR), and the band inside the box is the median. The ends of the whiskers represent the minima and maxima without outliers. The value of P was determined by ANOVA with Tukey–Kramer post hoc testing. (*P < 0.05, **P < 0.01)CC BY · PubMed Central
Fig. 2 Hepatic IRS-1 and IRS-2 mRNA levels correlated with gluconeogenesis and lipogenesis gene expressions. The scatter plots show the relationship of IRS-1 mRNA levels with PEPCK (a) or G6Pase (c) or FAS (e) mRNA levels or the IR-B/IR-A mRNA ratio (g), and the relationship of IRS-2 mRNA levels with PEPCK (b) or G6Pase (d) or FAS (f) mRNA levels or the IR-B/IR-A mRNA ratio (h). The data from 51 human liver biopsies are shown. Gene expressions are normalized to CDKN1B mRNA levels. The lines indicate the linear regressions between the parameters. The value of P was determined by Pearson’s test
Fig. 2 Hepatic IRS-1 and IRS-2 mRNA levels correlated with gluconeogenesis and lipogenesis gene expressions. The scatter plots show the relationship of IRS-1 mRNA levels with PEPCK (a) or G6Pase (c) or FAS (e) mRNA levels or the IR-B/IR-A mRNA ratio (g), and the relationship of IRS-2 mRNA levels with PEPCK (b) or G6Pase (d) or FAS (f) mRNA levels or the IR-B/IR-A mRNA ratio (h). The data from 51 human liver biopsies are shown. Gene expressions are normalized to CDKN1B mRNA levels. The lines indicate the linear regressions between the parameters. The value of P was determined by Pearson’s testCC BY · PubMed Central
Fig. 3 Insulin signaling in the liver of subjects with normal liver and NAFLD. The expression of insulin receptor substrates-2 (IRS-2) is decreased, while the expression of phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase) are increased in patients with NAFLD. In contrast, the expression of IRS-1 is unaltered and the expression of fatty acid synthase (FAS) is increased in patients with NAFLD
Fig. 3 Insulin signaling in the liver of subjects with normal liver and NAFLD. The expression of insulin receptor substrates-2 (IRS-2) is decreased, while the expression of phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase) are increased in patients with NAFLD. In contrast, the expression of IRS-1 is unaltered and the expression of fatty acid synthase (FAS) is increased in patients with NAFLDCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 50 references

Cited by

See all 117

Metadata

Authors
Honma, M., Sawada, S., Ueno, Y., Murakami, K., Yamada, T., Gao, J., Kodama, S., Izumi, T., Takahashi, K., Tsukita, S., Uno, K., Imai, J., Kakazu, E., Kondo, Y., Mizuno, K., Kawagishi, N., Shimosegawa, T., & Katagiri, H.
Affiliations
  • Tohoku University (JP)
  • Yamagata University (JP)
  • Tohoku University Hospital (JP)
Corresponding author
  • Sawada, Shojiro
  • Katagiri, Hideki
Venue
International Journal of Obesity
Published
2018-05-01
Volume
42
Issue
9
Pages
1544-1555
ISSN
  • 0307-0565 (ISSN-L)
  • 1476-5497
OpenAlex
W2802224281
Cited by
108
References
50
Citations by year
2026: 5 · 2025: 20 · 2024: 14 · 2023: 10 · 2022: 8 · 2021: 19 · 2020: 19 · 2019: 9 · 2018: 4
FWCI
10.52
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/4.0 (tdm)
Locations
  • International Journal of Obesity (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by-nc-nd)
Funders
Japan Society for the Promotion of Science (16K09773, 18H02858, 25253067, 18K16221, 17K09816)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
Keywords
non-alcoholic fatty liver disease, IRS-1, insulin receptor substrate 2, gluconeogenesis, lipogenesis, fatty acid synthase, hepatic steatosis, nonalcoholic steatohepatitis, liver biopsy, gene expression
MeSH terms
Adult, Biopsy, Female, Humans, Insulin Resistance, Liver, Male, Middle Aged, Case-Control Studies, Insulin Receptor Substrate Proteins, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Selective insulin resistance with differential expressions of IRS-1 and IRS-2 in human NAFLD livers. https://app.cochat.ai/papers/10.1038/s41366-018-0062-9
The paper
Honma, M., Sawada, S., Ueno, Y., Murakami, K., Yamada, T., Gao, J., Kodama, S., Izumi, T., Takahashi, K., Tsukita, S., Uno, K., Imai, J., Kakazu, E., Kondo, Y., Mizuno, K., Kawagishi, N., Shimosegawa, T., & Katagiri, H. (2018). Selective insulin resistance with differential expressions of IRS-1 and IRS-2 in human NAFLD livers. International Journal of Obesity. https://doi.org/10.1038/s41366-018-0062-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.